) has been revised to $1.02 / share. This is a decrease of 50.00% from the prior estimate of $2.04 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...
The average one-year price target for Milestone Scientific (NYSEAM:MLSS) has been revised to $2.04 / share. This is an increase of 23.08% from the prior estimate of $1.66 dated September 27, 2025. The ...
Milestone’s commercial strategy includes deploying 60 representatives who will target between 10,000 and 15,000 high-volume prescribers, according to Jefferies’ research. The firm indicated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback